MENTA CAPITAL LLC - SUPERNUS PHARMACEUTICALS INC ownership

SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 208 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q4 2015. The put-call ratio across all filers is 0.97 and the average weighting 0.2%.

Quarter-by-quarter ownership
MENTA CAPITAL LLC ownership history of SUPERNUS PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2019$259,000
-5.5%
7,8240.0%0.11%
-8.3%
Q1 2019$274,000
+5.4%
7,8240.0%0.12%
+25.0%
Q4 2018$260,000
-31.8%
7,824
+3.5%
0.10%
-27.8%
Q3 2018$381,000
-17.7%
7,559
-2.4%
0.13%
+23.1%
Q2 2018$463,000
-4.1%
7,743
-26.6%
0.11%
+4.9%
Q1 2018$483,000
+14.2%
10,543
-0.7%
0.10%
+25.6%
Q4 2017$423,000
+0.2%
10,615
+0.7%
0.08%
+32.3%
Q3 2017$422,000
-20.1%
10,543
-13.9%
0.06%
-1.6%
Q2 2017$528,000
-81.4%
12,243
-86.5%
0.06%
-77.3%
Q1 2017$2,840,000
-25.4%
90,735
-39.8%
0.28%
-12.6%
Q4 2016$3,806,000
-22.3%
150,716
-23.9%
0.32%
-31.9%
Q3 2016$4,899,000
+89.2%
198,109
+55.9%
0.47%
+31.2%
Q2 2016$2,589,000
+263.6%
127,080
+172.3%
0.36%
+267.0%
Q1 2016$712,000
-19.5%
46,673
-29.1%
0.10%
-13.4%
Q4 2015$885,000
-10.3%
65,865
-6.4%
0.11%
-28.2%
Q3 2015$987,000
-56.8%
70,384
-47.7%
0.16%
-58.2%
Q2 2015$2,284,000
+12.1%
134,529
-20.2%
0.37%
+41.8%
Q1 2015$2,038,000
+163.0%
168,597
+80.5%
0.26%
+139.1%
Q4 2014$775,00093,4010.11%
Other shareholders
SUPERNUS PHARMACEUTICALS INC shareholders Q4 2015
NameSharesValueWeighting ↓
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 426,500$11,754,3403.96%
ASHFORD CAPITAL MANAGEMENT INC 916,747$25,274,7153.72%
ARMISTICE CAPITAL, LLC 5,092,000$140,386,4402.15%
S&T BANK/PA 215,578$5,9431.15%
Aristotle Capital Boston, LLC 1,187,981$32,752,6341.06%
RICE HALL JAMES & ASSOCIATES, LLC 544,468$15,010,9830.95%
Tributary Capital Management, LLC 352,429$9,716,4680.92%
Bridge City Capital, LLC 65,297$1,800,2380.91%
Integral Health Asset Management, LLC 220,000$6,065,4000.84%
Retirement Planning Co of New England, Inc. 51,608$1,422,8330.79%
View complete list of SUPERNUS PHARMACEUTICALS INC shareholders